Role of ferroptosis in atrial fibrillation: a review

Shaowei Fan1, Yuanhui Hu2, Jingjing Shi2

  • 1Lugouqiao Second Community Health Service Center, China Aerospace Science & Industry Corporation 731 Hospital, Beijing, China.

Frontiers in Pharmacology
|February 21, 2025
PubMed

Insights

Ferroptosis, a cell death process involving iron, may contribute to atrial fibrillation development. Further research is needed to understand this link between ferroptosis and cardiovascular disease.

Area of Science:

  • Biomedical research
  • Cardiovascular science
  • Cellular biology

Background:

  • Cardiovascular disease is a leading cause of death.
  • Atrial fibrillation is a common cardiac condition with unclear mechanisms.
  • Ferroptosis, a form of regulated cell death, is implicated in various diseases.

Purpose of the Study:

  • To explore the potential role of ferroptosis in atrial fibrillation pathogenesis.
  • To review current evidence linking ferroptosis to atrial fibrillation.
  • To provide an overview of ferroptosis mechanisms in the context of atrial fibrillation.

Main Methods:

  • Literature review of ferroptosis and atrial fibrillation research.
  • Analysis of existing studies on cell death pathways in cardiac conditions.
  • Synthesis of evidence regarding iron overload and lipid peroxidation in atrial fibrillation.

Main Results:

  • Ferroptosis, characterized by iron accumulation and lipid peroxidation, is a recognized cell death pathway.
  • Emerging evidence suggests ferroptosis may be involved in atrial fibrillation.
  • Mechanisms linking ferroptosis to atrial fibrillation are still under investigation.

Conclusions:

  • Ferroptosis presents a potential novel mechanism in atrial fibrillation.
  • Understanding ferroptosis could offer new therapeutic targets for atrial fibrillation.
  • More research is required to elucidate the precise role of ferroptosis in atrial fibrillation.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.3K
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.8K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.5K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
598
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K